Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands
申请人:Wyeth
公开号:US20040002527A1
公开(公告)日:2004-01-01
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
1
本发明提供了一种公式I的化合物,以及该化合物用于治疗与5-HT6受体相关或受其影响的疾病。